Another iPS product approved for public insurance coverage in Japan
It is the second case of insurance coverage approval in the nation for an induced pluripotent stem cell-derived regenerative medicine product.
It is the second case of insurance coverage approval in the nation for an induced pluripotent stem cell-derived regenerative medicine product.
Original source:The Japan Times ↗
More Japan News
Will heat waves push European holidaymakers to ‘coolcations’?
The concept of "coolcations" — vacations in a cooler clime — has been gathering pace in recent years and appears to have exploded in 2026.
U.S. holds fire against Iran as reports emerge of stockpile concerns
The pause could reflect pressure on stockpiles of Patriot interceptors and other defensive weapons, U.S. media reports said.
Family Mart’s new Famima flagship in Tokyo has a hidden gem that most visitors miss
A must-try convenience store drink you won’t find anywhere else. Earlier this month, Family Mart shook up the convenience store scene by opening its first-ever flagship store, Famima Park Azabudai. Lo